Ensho Therapeutics Company Profile
Ensho Therapeutics, founded in 2024 and headquartered in Morris Plains, NJ, is a private biopharmaceutical company with 11 employees focused on developing oral, selective small molecule inhibitors targeting lymphocyte homing integrin to treat inflammatory bowel disease, having raised $27.9 million through multiple early-stage VC funding rounds currently in Phase 2 clinical trials.
Overview
Ensho Therapeutics is a privately held biopharmaceutical company founded in 2024. The company is focused on developing oral therapies for patients with inflammatory diseases, specifically offering oral, selective small molecule inhibitors of lymphocyte homing integrin. This mechanism is already validated by a commercially available antibody, enabling treatment for people suffering from inflammatory bowel disease.
- Status: Private
- Employees: 11
- Primary Industry: Drug Discovery
- Other Industries: Biotechnology, Pharmaceuticals
- Verticals: HealthTech, Life Sciences
- Corporate Office:
- 422 Mountain Way, Morris Plains, NJ 07950, United States
- +1 (973)
- Website: www.enshorx.com
Valuation & Funding
- Latest Deal Type: Early Stage VC (In Progress)
- Investors: 2
- Funding Rounds:
- Early Stage VC (Series A): $5.4M raised on 12-Nov-2024 (Clinical Trials - Phase 2)
- Early Stage VC (Series A2): Completed on 12-Sep-2025 (Clinical Trials - Phase 2)
- Early Stage VC: In Progress as of 09-Feb-2026 (Clinical Trials - Phase 2)
- Total Funding Raised: $27.9M
Investors
- Avego Management (PE/Buyout, Minority)
- Global BioAccess Fund (Venture Capital, Minority)
Frequently Asked Questions
When was Ensho Therapeutics founded?
Ensho Therapeutics was founded in 2024.
Where is Ensho Therapeutics headquartered?
Ensho Therapeutics is headquartered in Morris Plains, NJ.
What is the size of Ensho Therapeutics?
Ensho Therapeutics has 11 total employees.
What industry is Ensho Therapeutics in?
Ensho Therapeutics’s primary industry is Drug Discovery.
Is Ensho Therapeutics a private or public company?
Ensho Therapeutics is a Private company.
What is Ensho Therapeutics’s current revenue?
The current revenue for Ensho Therapeutics is not disclosed.
How much funding has Ensho Therapeutics raised over time?
Ensho Therapeutics has raised $27.9M.
Who are Ensho Therapeutics’s investors?
Avego Management and Global BioAccess Fund have invested in Ensho Therapeutics.